IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,521 | +10.6% | 739 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $30,321 | +15.1% | 739 | +0.3% | 0.01% | 0.0% |
| Q1 2023 | $26,340 | -4.9% | 737 | +0.5% | 0.01% | 0.0% |
| Q4 2022 | $27,685 | -16.1% | 733 | -0.8% | 0.01% | -28.6% |
| Q3 2022 | $33,000 | +22.2% | 739 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $27,000 | -10.0% | 739 | -10.1% | 0.01% | +20.0% |
| Q1 2022 | $30,000 | +130.8% | 822 | +94.3% | 0.01% | +150.0% |
| Q4 2021 | $13,000 | -13.3% | 423 | -3.6% | 0.00% | -33.3% |
| Q3 2021 | $15,000 | +200.0% | 439 | +262.8% | 0.00% | +200.0% |
| Q2 2021 | $5,000 | -28.6% | 121 | -18.2% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -56.2% | 148 | -50.0% | 0.00% | -50.0% |
| Q4 2020 | $16,000 | +45.5% | 296 | +23.8% | 0.00% | -33.3% |
| Q3 2020 | $11,000 | 0.0% | 239 | +22.6% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +83.3% | 195 | +57.3% | 0.00% | +50.0% |
| Q1 2020 | $6,000 | -50.0% | 124 | -39.5% | 0.00% | -60.0% |
| Q4 2019 | $12,000 | 0.0% | 205 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $12,000 | -7.7% | 205 | +1.0% | 0.01% | 0.0% |
| Q2 2019 | $13,000 | -18.8% | 203 | +1.5% | 0.01% | -28.6% |
| Q1 2019 | $16,000 | +220.0% | 200 | +100.0% | 0.01% | +133.3% |
| Q4 2018 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $4,000 | -71.4% | 100 | -65.0% | 0.00% | -70.0% |
| Q4 2016 | $14,000 | +250.0% | 286 | +186.0% | 0.01% | +233.3% |
| Q3 2016 | $4,000 | +100.0% | 100 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $2,000 | -50.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,000 | -33.3% | 100 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $6,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |